(6) Prospects and Reasonable Treatment of Coronary Atherosclerotic Heart Disease in Japan

Japanese Journal of Medicine
doi 10.2169/internalmedicine1962.17.369
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Society of Internal Medicine

Related search

Correlations of Chemokine CXCL16 and TNF-α With Coronary Atherosclerotic Heart Disease

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2017English

Theophylline Therapy and the Risk of Atherosclerotic Coronary Heart Disease in Asthmatic Children

Journal of Medical Sciences
Medicine
2007English

Familial Hypercholesterolemia With Early Coronary Atherosclerotic Heart Disease: A Case Report

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2019English

Antiplatelet Treatment for Coronary Heart Disease

Heart
Cardiovascular MedicineCardiology
2005English

Secular Changes in Rates of Coronary Heart Disease, Fatal Coronary Heart Disease, and Out-Of-Hospital Fatal Coronary Heart Disease

International Journal of Cardiology
Cardiovascular MedicineCardiology
2014English

Age-Dependent Effect of Metabolic Phenotypes on Carotid Atherosclerotic Disease in Coronary Heart Disease Patients (CORDIOPREV Study)

BMC Geriatrics
GerontologyGeriatrics
2020English

The Role of Exercise in Prevention and in the Treatment of Coronary Heart Disease. Exercise in Coronary Disease.

British Journal of Sports Medicine
Sports MedicinePhysical TherapySports ScienceSports TherapyOrthopedicsMedicineRehabilitation
1976English

Role of Endogenous Oestrogen in Aetiology of Coronary Heart Disease: Analysis of Age Related Trends in Coronary Heart Disease and Breast Cancer in England and Wales and Japan

BMJ
2002English

Efficacy of Nebivolol in Treatment of Women With Coronary Heart Disease

Russian Journal of Cardiology
Cardiovascular MedicineCardiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy